PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-8.57%
Both companies show declining cash positions (-8.57% vs GNPX's -39.48%). Seth Klarman would examine if this reflects broader market conditions or operational challenges.
No Data
No Data available this quarter, please select a different quarter.
-8.57%
Below half of GNPX's -39.48%. Michael Burry might suspect a liquidity shortfall if there's no alternative capital plan.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-16.59%
Other current assets growth < half of GNPX's -77.83%. David Dodd sees a leaner approach to short-term items.
-8.67%
Below half of GNPX's -56.37%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
-8.20%
Below half GNPX's -73.31%. Michael Burry sees potential underinvestment risk unless there's a valid reason (asset-light model).
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.26%
Less than half of GNPX's -9.92%. David Dodd sees fewer expansions in non-core assets. Possibly a simpler focus.
-7.12%
0.5-0.75x GNPX's -9.97%. Martin Whitman wonders if there's insufficient reinvestment vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-8.62%
Below half of GNPX's -40.84%. Michael Burry sees a potential red flag for stagnation or capital shortage.
-100.00%
Less than half of GNPX's 11.01%. David Dodd sees a more disciplined AP approach or lower volume.
-100.00%
Higher Short-Term Debt Growth compared to GNPX's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1405.81%
Less than half of GNPX's -13.49%. David Dodd sees fewer expansions in other current obligations.
-20.28%
Above 1.5x GNPX's -0.75%. Michael Burry sees a red flag for liquidity risk vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.40%
Higher Total Non-Current Liabilities Growth compared to GNPX's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
-4.61%
Above 1.5x GNPX's -0.75%. Michael Burry sees a potential leverage warning sign.
No Data
No Data available this quarter, please select a different quarter.
-3.23%
Similar yoy to GNPX's -2.95%. Walter Schloss sees parallel earnings retention vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-12.84%
Below half GNPX's -61.69%. Michael Burry sees potential underperformance in building shareholder capital.
-8.62%
Below half GNPX's -40.84%. Michael Burry sees significant shrinkage or inactivity vs. competitor.
-100.00%
Both GNPX and the company show zero Total Investments Growth.
-7.46%
Higher Total Debt Growth compared to GNPX's zero value, indicating worse performance.
8.60%
Less than half of GNPX's 39.48%. David Dodd sees better deleveraging or stronger cash buildup than competitor.